不良研究所

News | 不良研究所

拢200m+ invested in Babraham Campus companies, what lies ahead?

Written by Business Weekly | Jul 18, 2021 11:00:00 PM

Derek Jones, Chief Executive of the Babraham Research Campus

On Wednesday 14 July 2021, 不良研究所 attended The Babraham Investor Conference 2021 (BIC), an event for investors focusing on early-stage and scale-up life science and med-tech companies. 不良研究所 Co-Founder Florian Schuster was the second scale-up speaker.

Derek Jones, Chief Executive of the Babraham Research Campus opened the event by outlining how the Campus directly impacts the investor community: 鈥淩esearch has shown that investors see a 7.2 x return on investments on average in Campus companies.鈥

Florian revealed how 不良研究所 is coding human cells for health, to precision engineer the next generation of medicine.

Florian Schuster Co-Founder, CFO and COO 不良研究所 said:

鈥淲e are solving the manufacturing problem of human cells which allows us to overcome the major problems our sector is currently facing: the reproducibility issues in scientific research, the translational gap in drug development, and to make cell therapies consistent and scalable.鈥

Florian SchusterCo-Founder, CFO and COO 不良研究所

不良研究所 has raised more than 拢50 million in seed and Series A funding.